Adage Capital discloses 7.25% Equillium (EQ) stake via Schedule 13G/A filing
Rhea-AI Filing Summary
Adage Capital Management, L.P. and affiliates report a 7.25% beneficial ownership stake in Equillium, Inc. The group, including Adage Capital Management, Robert Atchinson, and Phillip Gross, reports beneficial ownership of 4,832,767 shares of Equillium common stock, including 3,442,514 shares issuable upon exercise of warrants held by Adage Capital Partners, L.P. The ownership percentage is calculated based on 63,226,556 shares outstanding as of May 8, 2026, as disclosed in Equillium’s Form 10-Q for the quarter ended March 31, 2026. All reported shares are subject to shared voting and shared dispositive power among the reporting persons.
Positive
- None.
Negative
- None.
Key Figures
Beneficially owned shares: 4,832,767 shares
Ownership percentage: 7.25%
Warrant-related shares: 3,442,514 shares
+1 more
4 metrics
Beneficially owned shares
4,832,767 shares
Shares of Equillium common stock beneficially owned by the reporting persons
Ownership percentage
7.25%
Percent of Equillium common stock class beneficially owned by the reporting persons
Warrant-related shares
3,442,514 shares
Shares of common stock issuable upon exercise of warrants held by Adage Capital Partners, L.P.
Shares outstanding baseline
63,226,556 shares
Equillium common shares outstanding as of May 8, 2026, used to compute ownership percentage
Key Terms
beneficial ownership, shared voting power, shared dispositive power, Schedule 13G/A, +1 more
5 terms
beneficial ownership financial
"The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Schedule 13G/A regulatory
"The percentage set forth in this is calculated based upon an aggregate of 63,226,556 shares of Common Stock outstanding..."
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
warrants financial
"Includes 3,442,514 shares of Common Stock issuable upon exercise of warrants."
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in Equillium, Inc. (EQ) does Adage Capital report?
Adage Capital and related reporting persons report beneficial ownership of 4,832,767 shares of Equillium common stock, representing 7.25% of the class, including shares issuable upon exercise of warrants held by Adage Capital Partners, L.P.
How is the 7.25% beneficial ownership in Equillium (EQ) calculated?
The 7.25% ownership is calculated using 63,226,556 shares of Equillium common stock outstanding as of May 8, 2026, as reported in Equillium’s Form 10-Q for the quarter ended March 31, 2026.
Who are the reporting persons on this Schedule 13G/A for Equillium (EQ)?
The filing is made by Adage Capital Management, L.P., and by its associated principals Robert Atchinson and Phillip Gross, each reporting indirect beneficial ownership of Equillium common stock through Adage Capital Partners, L.P. and related entities.
Where is Adage Capital’s business office for this Equillium (EQ) holding?
The business office for each reporting person is listed as 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116, which serves as the address for Adage Capital Management and its principals regarding this ownership.